LBA1 Pembrolizumab in combination with xelox and bevacizumab in patients with microsatellite stable (pMMR/MSS) metastatic colorectal cancer (mCRC) and a high immune infiltrate: A proof of concept study - Preliminary results of FFCD 1703 POCHI trial
Year: 2024
Type: article
Source: Annals of Oncology
Institutions: Centre Hospitalier Universitaire de Poitiers, Hôpital Ambroise-Paré, Centre Hospitalier de Saint-Malo, Fédération Francophone de Cancérologie Digestive, Hôpital Saint Joseph, Centre François Baclesse, Centre Hospitalier Universitaire de Limoges, Hôpital Universitaire Dupuytren, Centre Hospitalier de Cornouaille, Fondation Cognacq-Jay, Centre Hospitalier de Perpignan, Infirmerie Protestante, Centre Hospitalier Départemental Vendée, Hôpital Pontchaillou, Centre Hospitalier Universitaire de Rennes, Institut Sainte Catherine, Centre Hospitalier Régional et Universitaire de Nancy, Université Paris Cité, CHU Dijon Bourgogne, Hôpital Européen Georges-Pompidou
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4400151376